Inventor · disambiguated record
Antoine Noujaim
Also filed as: NOUJAIM ANTOINE · NOUJAIM ANTOINE A
20 granted patents·19 pending applications·262 citations·filing 1988–2013
95Inventor score
Top patents by PatentIndex Score
39 records- 0190US6689355B2Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cellsALTAREX INC·Filed 2001·Granted Feb 10, 2004·37 cites·21 claims
- 0287US8007805B2Chimeric antigens for breaking host tolerance to foreign antigensPALADIN LABS INC·Filed 2004·Granted Aug 30, 2011·35 cites·29 claims
- 0386US6960352B2Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agentVIREXX MEDICAL CORP·Filed 2002·Granted Nov 1, 2005·22 cites·52 claims
- 0485US8465745B2Chimeric antigens for eliciting an immune responseGEORGE RAJAN·Filed 2011·Granted Jun 18, 2013·7 cites·26 claims
- 0585US8025873B2Chimeric antigens for eliciting an immune responsePALADIN LABS INC·Filed 2004·Granted Sep 27, 2011·13 cites·33 claims
- 0681US7387994B2Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agentVIREXX MEDCIAL CORP·Filed 2005·Granted Jun 17, 2008·4 cites·51 claims
- 0781US6881405B2Reagents and methods for inducing an immune response to prostate specific antigenALTAREX MEDICAL CORP·Filed 1999·Granted Apr 19, 2005·45 cites·9 claims
- 0881US6241985B1Method and composition for reconforming multi-epitopic antigens to initiate an immune responseALTAREX INC·Filed 1996·Granted Jun 5, 2001·29 cites·14 claims
- 0978US8637477B2Antigenic compositions and use of same in the targeted delivery of nucleic acidsGEORGE RAJAN·Filed 2008·Granted Jan 28, 2014·3 cites·9 claims
- 1077US7947282B2Methods of treatment using vascular occlusion in combination therapiesIMBIOTECHNOLOGIES LTD·Filed 2006·Granted May 24, 2011·3 cites·15 claims
- 1175US7390488B2Compositions and methods for producing vascular occlusionVIREXX MEDICAL CORP·Filed 2005·Granted Jun 24, 2008·1 cites·14 claims
- 1273US8029803B2Chimeric antigens for eliciting an immune responsePALADIN LABS INC·Filed 2003·Granted Oct 4, 2011·8 cites·40 claims
- 1371US8038994B2Combination therapy for treating diseaseQUEST PHARMATECH INC·Filed 2004·Granted Oct 18, 2011·3 cites·20 claims
- 1471US2008311127A1Combination therapy for treating diseaseALTAREX MEDICAL CORP·Filed 2007·Application pending·0 cites
- 1569US6887474B1Compositions and methods for producing vascular occlusionVIREXX MEDICAL CORP·Filed 1999·Granted May 3, 2005·15 cites·5 claims
- 1667US2007036798A1Method and composition for reconforming multi-epitopic antigens to initiate an immune responseALTAREX MEDICAL CORP·Filed 2006·Application pending·0 cites
- 1765US2008131443A1Method and composition for reconforming multi-epitopic antigens to intiate an immune responseALTAREX MEDICAL CORP·Filed 2007·Application pending·0 cites
- 1865US2008206318A1Therapeutic compositions that alter the immune responseMADIYALAKAN RAGUPATHY·Filed 2007·Application pending·0 cites
- 1964US6086873ATherapeutic composition and method of treatmentALTAREX INC·Filed 1997·Granted Jul 11, 2000·10 cites·5 claims
- 2061US2006159688A1Method for diagnosing efficacy of xenotypic antibody therapyMADIYALAKAN RAGUPATHY·Filed 2004·Application pending·0 cites
- 2159US2013302330A1Chimeric antigens for eliciting an immune responseAKSHAYA BIO INC·Filed 2013·Application pending·0 cites
- 2259US2013295610A1Chimeric antigens for eliciting an immune responseHIRSCHE BRUCE D·Filed 2013·Application pending·0 cites
- 2358US2007092522A1Method and composition for reconforming multi-epitopic antigens to initiate an immune responseALTAREX MEDICAL CORP·Filed 2006·Application pending·0 cites
- 2457US7579445B2Reagents and methods for inducing an immune response to prostate specific antigenALTAREX MEDICAL CORP·Filed 2004·Granted Aug 25, 2009·0 cites·9 claims
- 2557US2001036457A1Method and composition for reconforming multi-epitopic antigens to initiate an immune responseFiled 2001·Application pending·0 cites
- 2657US2008220012A1Therapeutic Compositions that alter the immune responseMADIYALAKAN RAGUPATHY·Filed 2007·Application pending·0 cites
- 2757US2009220493A1Reagents and methods for inducing an immune response to prostate specific antigenALTAREX MEDICAL CORP·Filed 2007·Application pending·0 cites
- 2857US2002168366A1Compositions and methods for producing vascular occlusionFiled 2002·Application pending·0 cites
- 2956US2004191236A1Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cellsFiled 2003·Application pending·0 cites
- 3055US2009202560A1Method for diagnosing efficacy of xenotypic antibody therapyALTAREX MEDICAL CORP·Filed 2007·Application pending·0 cites
- 3153US2014187752A1Antigenic compositions and use of same in the targeted delivery of nucleic acidsAKSHAYA BIO INC·Filed 2013·Application pending·0 cites
- 3250US2009238822A1Chimeric Hepatitis C Virus Antigens For Eliciting an Immune ResponseVIREXX MEDICAL CORP·Filed 2006·Application pending·0 cites
- 3349US2005079179A1Compositions and methods for producing vascular occlusionFiled 2002·Application pending·0 cites
- 3447US6313274B1Photoactivation of proteins for conjugation purposesFiled 1993·Granted Nov 6, 2001·15 cites·42 claims
- 3545US2011223185A1Chimeric hepatitis c virus antigens for eliciting an immune responseGEORGE RAJAN·Filed 2011·Application pending·0 cites
- 3641US2002022235A1Method for diagnosing efficacy of xenotypic antibody therapyFiled 2001·Application pending·0 cites
- 3736US7361346B1Therapeutic compositions that produce an immune responseALTAREX INC·Filed 1998·Granted Apr 22, 2008·2 cites·37 claims
- 3834US7318921B2Therapeutic compositions that alter the immune responseALTAREX MEDICAL CORP·Filed 1999·Granted Jan 15, 2008·3 cites·76 claims
- 3931US4990326AMethod for detecting blood plateletsSUMMA MEDICAL CORP·Filed 1988·Granted Feb 5, 1991·7 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Antoine Noujaim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →